top of page
Untitled_Artwork.png

History of Cannabis

Welcome Spaced Cadets! We have been talking a lot about cannabinoids, and terpenes, and mentioned the biosynthesis of the cannabinoids. This blog will be about the history of cannabis and where it all started! 

 

Cannabis has dated more than 12,000 years ago from where records were starting to be found. There were notes found from Ancient Assyria referencing a plant/drug that is medicinal cannabis in Cuneiform tablets. Ancient Assyria dates from 2025 BC to the earliest AD 240, as cannabis has been helping way before we were born. 

While in ancient Egypt dating back to 1700 BCE, they called it shemshemet. They used it variously to help with pain and infections. India used it spiritually to try and balance their nervous system. By the 11-12th century, India had published definitive records for medical cannabis. China is the main country that published the first pharmacopeia that included cannabis. It was written in the 1st or 2nd century CE and was called ma. A translation from the Ben Cao Jing on ma (cannabis) was “Governs the five taxations and seven damages, benefits the five viscera, and descends blood and cold qi; excessive consumption causes one to see ghosts and run about frenetically.” 


In Western Europe, they failed to study or acknowledge medicinal cannabis in the Middle Ages. It was not till the 18thcentury that Napoleon Bonaparte and his soldiers popularized recreational cannabis in Western Europe. An Irish physician William Brook O'Shaughnessy brought cannabis to modern Western medicine in 1839. He performed experiments on animals to see if there were harmful side effects and came to the conclusion there were none. O’Shaughnessy was the reason as well for the adoption of cannabis in North America. 


In the United States O’Shaughnessy’s findings were confirmed with additional human trials. Cannabis as Extract of Hemp was published in 1850 in the United States Pharmacopeia and patented hemp tinctures that were for insomnia, pain, and arthritis. In 1906 the United States passed the Food & Drug Act that required correct labeling of cannabis. In 1918 the United States produced 60,000 pounds of domestic cannabis to supply pharmacies. But it all came to a sad end when Cannabis was classified as a Schedule I substance in 1970 with the passing of the Controlled Substances Act (CSA).

 

Cannabis has been around for a long time and was used as we are using it today.  As a form of medicine, or to help with pain and inflammation. Each country had its name for it and used it for different purposes, but all had the same main goal, to help our people feel better.


Sources

Clarke RC, Merlin MD. Cannabis: Evolution and Ethnobotany. University of California Press; 2013. 

 

Lynch RC, Vergara D, Tittes S, et al. Genomic and chemical diversity in cannabis. Crit Rev Plant Sci. 2016;35(5-6):349-363. doi:10.1080/07352689.2016.1265363 

 

Duvall C. Ancient cannabis. In: Cannabis. Reaktion Books LTD; 2014. 

 

Liu F-H, Hu H-R, Du G-H, Deng G, Yang Y. Ethnobotanical research on origin, cultivation, 

distribution and utilization of hemp (Cannabis sativa L.) in China. IJTK. 2017;16(2):235-242. 

Russo EB. Hemp for headache: An in-depth historical and scientific review of cannabis 

in migraine treatment. Journal of Cannabis Therapeutics. 2001;1(2):21-92. doi:10.1300/ 

j175v01n02_04 

 

Mechoulam R. The pharmacohistory of ancient cannabis. In: Mechoulam R, ed. Cannabi- 

noids as Therapeutic Agents. CRC Press; 1986. 

 

Russo EB. Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy Be- hav. 2017;70:292-297. doi:10.1016/j.yebeh.2016.09.040 

 

Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 2007;4(8):1614-1648. doi:10.1002/cbdv.200790144 

 

Grierson GA. The hemp plant in Sanskrit and Hindi literature. The Indian Antiquary. 1894;23: 260. 

 

Padhy S, Dash SK. The soma drinker of ancient India: an ethno-botanical retrospection. J Hum Ecol. 2004;15(1):19-26. doi:10.1080/09709274.2004.11905661 

 

Russo EB. Cannabis in India: ancient lore and modern medicine. Mechoulam R, ed. Can- nabinoids as Therapeutics. 2006:1-22. doi:10.1007/3-7643-7358-x_1 

 

Wedman-St.Louis B. Cannabis use in Chinese medicine, ayurvedic medicine, & different religions. In: Cannabis as Medicine. 1st ed. CRC Press; 2019. 

 

Booth M. Out of the land of mulberry and hemp. In: Cannabis: A History. New York: Pica- dor; 2003. 

 

Aldrich M. The history of therapeutic cannabis. In: Cannabis in Medical Practice: A Legal, Historical, and Pharmacological Overview of the Therapeutic Use of Marijuana. Jefferson, NC: McFarland & Company, Inc.; 1997:35-36. 

Brand EJ, Zhao Z. Cannabis in Chinese medicine: are some traditional indications refer- enced in ancient literature related to cannabinoids? Front Pharmacol. 2017;8. doi:10.3389/ fphar.2017.00108 

 

Ziegler J. Religion and medicine in the Middle Ages. In: Biller P and Ziegler J, eds. Religion and Medicine in the Middle Ages. Great Britain: York Medieval Press; 2001. 

 

Minkowski WL. Women healers of the middle ages: selected aspects of their history. Am J Public Health. 1992;82(2):288-295. doi:10.2105/ajph.82.2.288 

 

Alakbarov FU. Medicinal properties of cannabis according to medieval manuscripts of Azerbaijan. Journal of Cannabis Therapeutics. 2001;1(2):3-14. doi:10.1300/j175v01n02_02 

 

Fabre AJ. [Cannabis, hemp and hashish: always returning]. Histoire des Sciences Medi- cales. 2006; 40(2):191-202. 

 

O’Shaughnessy WB. Extract from a memoir on the preparations of the Indian hemp, or gunjah, (Cannabis indica) their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. J Asiat Soc Bengal. 1839; 8(94): 733. 

 

Oshaughnessy WB. On the preparations of the Indian hemp, or gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. BMJ. 1843;s1-5(123):363-369. 

 

Donovan M. On the physical and medicinal qualities of Indian hemp (Cannabis Indica); with observations on the best mode of administration, and cases illustrative of its pow- ers. The Dublin Journal of Medical Science. 1845;26(3):368-402. doi:10.1007/bf02971741 

 

Wood, GB. The Pharmacopeia of the United States of America. Philadelphia: Lippincott, Grambo, & Co; 1851. 

 

Dach J, Moore E, Kander J. Cannabis Extracts in Medicine: The Promise of Benefits in Seizure Disorders, Cancer, and Other Conditions. United States of America: McFarland & Company, Inc.; 2015. 

 

McMeens RR. Report of the Ohio State Medical Committee on Cannabis indica, in Trans- actions of the Fifteenth Annual Meeting of the Ohio State Medical Society at Ohio White Sulphur Springs. Ohio State Medical Society; 1860. 

 

Brown J. W Braithwaite and James Braithwaite, eds. The Retrospect of Medicine: Being a Half-Yearly Journal Containing a Retrospective View of Every Discovery and Practical Improvement in the Medical Sciences. London: Simpkin, Marshall, and Co.; 1883: 125. 

Oliver J. On the action of Cannabis indica. BMJ. 1883;1(1167):905-906. doi:10.1136/ bmj.1.1167.905-a 

Boes CJ. Osler on migraine. Can J Neurol Sci. 2015;42(2):144-147. doi:10.1017/cjn.2015.6 

 

Bliss M. William Osler a Life in Medicine. Oxford: Oxford Univ. Press; 2007. 

 

Molnar H. The Four Founding Physicians. Johns Hopkins Medicine. Baltimore, Maryland. 

https://www.hopkinsmedicine.org/about/history/history5.html. Published July 16, 2014. Accessed November 2, 2019. 

 

Fankhauser M. Chapter 1: cannabis as medicine in Europe in the 19th century. In: A Canna- bis Reader: Global Issues and Local Experiences: Volume 1. Lisbon: EMCDD; 2008. 

Pure Food and Drug Act. Fifty-ninth Congress, Sess. I, ch. 3914, 3915. 1906: 768-772. https://www.loc.gov/law/help/statutes-at-large/59th-congress/session-1/c59s1ch3915.pdf. Accessed: November 4, 2019. 

 

Padwa H, Cunningham J. Boylan Act. In: Addiction: A Reference Encyclopedia. ABC–Clio; 2010. 

Musto DF. The 1937 Marijuana Tax Act. Arch Gen Psychiatry. 1972;26(2):101-108. doi:10.1001/archpsyc.1972.01750200005002 

 

Gieringer DH. The forgotten origins of cannabis prohibition in California. Contemp Drug Probl. 1999;26(2):237-288. doi:10.1177/009145099902600204 

 

Ayenigbara GO. Medical utility of Cannabis sativa. IOSRPHR. 2012;2(3):460-463. doi:10.9790/3013-0230460463 

 

Cannadonna. Official Gazette of the United States Patent Office, Volume 273: p 373 

 

Duvall C. Cannabis. London: Reaktion Books (author’s manuscript); 2015: 97. 

 

Texas State Library and Archive Commission. Rangers and Outlaws. https://www.tsl.texas

gov/treasures/law/index.html. Accessed November 3, 2019. 

 

Stahnisch FW, Verhoef M. The Flexner Report of 1910 and its impact on complementary 

and alternative medicine and psychiatry in North America in the 20th century. Evid Based 

Complement Alternat Med. 2012:1-10. doi:10.1155/2012/647896 

 

Kentucky Hempsters. Did the Industrial Value of Hemp Spark Cannabis Prohibition? Leafly. 

hibition. Published September 15, 2017. Accessed November 3, 2019. 

 

ber 3, 2019. 

 

Limer E. Back When We Thought Hemp Would Be a Billion-Dollar Crop. Popular Mechan- 

ics. https://www.popularmechanics.com/science/environment/a19876318/popular-mechan- ics-billion-dollar-hemp/. Published April 20, 2018. Accessed November 3, 2019. 

 

Spunt B. Marijuana Tax Act. In: Larry Sullivan and Marie Rosen (eds.) Encyclopedia of Law Enforcement, Volume 1. Sage Publications; 2005. 

 

Powers RG, Mcwilliams JC. The protectors: Harry J. Anslinger and the Federal Bureau of Narcotics, 1930-1962. AHR. 1991;96(5):1633. doi:10.2307/2165463 

 

Schlussel D. The mellow pot-smoker: white individualism in marijuana legalization cam- paigns. Calif L Rev. 2017; 885. https://doi.org/10.15779/Z38PZ51K8D 

 

Reefer Madness. IMDb. https://www.imdb.com/title/tt0028346/. Published November 16, 2002. Accessed November 3, 2019. 

 

Grinspoon L. Marihuana as medicine: a plea for reconsideration. JAMA. 1995;273(23):1875- 1876. doi:10.1001/jama.273.23.1875 

 

Dickson DT. Bureaucracy and morality: an organizational perspective on a moral cru- sade. Drugs and Politics. 2017:31-53. doi:10.4324/9780203792858-3 

 

Letter from the American Medical Association – The Marihuana Tax Act of 1937. http:// www.druglibrary.org/schaffer/hemp/taxact/t8.htm. Accessed November 3, 2019. 

 

United States Pharmacopeia Convention. The Pharmacopeia of the United States of America — Twelfth Revision. Easton, PA: Mack Printing Co.; 1942. 

 

Davis JP, Ramsey HH. Anti-epileptic action of marijuana-active substances. FASEB. 1949;8(lY49): 284. 

 

Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. JACS. 1964;86(8):1646-1647. doi:10.1021/ja01062a046 

 

O’Bryan SM. Recent decisions: constitutional law—freedom of religion—use of drugs [Leary v. United States, 383 F.2d 851 (5th Cir. 1967), cert. granted, 36 U.S.L.W. 3473 (U.S. June 10, 1968) (No. 1365)]. Case W Res L Rev. 1968;251. 

 

Title 21 United States Code (USC) Controlled Substances Act. Section 812. https://www. deadiversion.usdoj.gov/21cfr/21usc/812.htm. Accessed November 3, 2019. 

 

Sacco LN. Drug enforcement in the United States: history, policy, and trends. Congressio- nal Research Service. 2014. https://fas.org/sgp/crs/misc/R43749.pdf 

 

Baum D. [Report]: Legalize It All. Harper’s magazine. https://harpers.org/archive/2016/04/ legalize-it-all/. Published March 31, 2016. Accessed November 3, 2019. 

 

Ben-Shabat S, Fride E, Sheskin T, et al. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharma- col. 1998;353(1):23-31. doi:10.1016/s0014-2999(98)00392-6 

 

Hurley R. “Illogical” cannabis regulation blocks research into therapeutic uses, say doc- tors. BMJ. 2018. doi:10.1136/bmj.k2780 

 

Provision of Marijuana and Other Compounds for Scientific Research - Recommendations. 

NIDA Archives. https://archives.drugabuse.gov/advisory-council-minutes/provision-mari- juana-other-compounds-scientific-research-recommendations. Published January 1, 1998. Accessed November 3, 2019. 

 

Doblin RE. [Thesis:] Regulation of the medical use of psychedelics and marijuana. Cam- bridge, Massachusetts: Harvard University; 2001. 

 

Food and Drug Administration. Highlights of Prescribing Information (Marinol). https:// www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf. Revised August 2017. Accessed November 3, 2019. 

 

Young FL. In The Matter of Marijuana Rescheduling Petition, Docket No. 86-22: Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of Adminis- trative Law Judge. Schaffer Library of Drug Policy. September 6, 1988. 

 

Hayes JS, Lampart R, Dreher MC, Morgan L. Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. West Indian Med J. 1991;40(3):120-23. 

 

Pertwee, Roger G. Cannabinoid pharmacology: the first 66 years. Bri J Pharma- col. 2006;147: 163-171. 

 

Compassionate Use Act of 1996. Health and Safety Code, Division 10, Chapter 6, Article 2 (Cannabis). https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?section- Num=11362.5.&lawCode=HSC. Accessed November 3, 2019. 

 

UK Parliament, Select Committee on Science and Technology Ninth Report. Medicinal Use of Cannabis: Recommendations. https://publications.parliament.uk/pa/ld199798/ldselect/ ldsctech/151/15110.htm#a24. 1998. Accessed November 3, 2019. 

 

About Us. GW Pharmaceuticals. https://www.gwpharm.com/about. Accessed November 4, 2019. 

GW Pharmaceuticals’ cannabinoid-medicine Sativex® moved to Schedule 4 of UK Drugs Act. GW Pharmaceuticals, plc. https://www.gwpharm.com/about/news/gw-pharmaceuti- cals-cannabinoid-medicine-sativexr-moved-schedule-4-uk-drugs-act. Accessed November 4, 2019.


2 views0 comments

Recent Posts

See All

Comments


bottom of page